scispace - formally typeset
M

Mary D Fortune

Researcher at University of Cambridge

Publications -  23
Citations -  1434

Mary D Fortune is an academic researcher from University of Cambridge. The author has contributed to research in topics: Genome-wide association study & Single-nucleotide polymorphism. The author has an hindex of 11, co-authored 17 publications receiving 986 citations. Previous affiliations of Mary D Fortune include Wellcome Trust Sanger Institute.

Papers
More filters
Journal ArticleDOI

Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases

TL;DR: The utility of integrating genetic studies of disease and gene expression for highlighting causal genes and cell types is demonstrated, including for CTSH, the expression of which in monocytes, but not in B cells, may mediate type 1 diabetes and narcolepsy associations in the chromosome 15q25.1 region.
Journal ArticleDOI

Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls

TL;DR: Two colocalization methods are extended to allow for the shared-control design commonly used in comparison of genome-wide association study results across diseases, suggesting a shared cellular etiology of autoimmune diseases.
Journal ArticleDOI

Uganda Genome Resource Enables Insights into Population History and Genomic Discovery in Africa

Deepti Gurdasani, +68 more
- 31 Oct 2019 - 
TL;DR: The largest study of its kind, comprising genome-wide data from 6,400 individuals and whole-genome sequences from rural Uganda, finds evidence of geographically correlated fine-scale population substructure.

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

TL;DR: A comparative analysis with 15 immune diseases showed that T1D is more similar genetically to other autoantibody-positive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least similar to ulcerative colitis, and provided support for three additional new T1d risk loci.